“MOLECULAR DOCKING INVESTIGATION OF VANILLIN-SCHIFF BASES AS A ARABINOSYLTRANSFERASE-C INHIBITORS”. 2025. Frontier in Medical and Health Research 3 (5): 1666-73. https://fmhr.net/index.php/fmhr/article/view/745.